New hope to fight devastating weight loss in liver cancer
NCT ID NCT07356037
Summary
This study is testing whether adding a drug called nanocrystalline megestrol acetate to standard liver cancer treatment can help patients who are experiencing severe, disease-related weight loss and poor appetite. The goal is to see if this combination helps people eat better and gain weight compared to standard treatment alone. The trial will enroll 68 adults with a specific stage of liver cancer who are already experiencing or at risk for this debilitating weight loss.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CACHEXIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China School of Medicine/West China Hospital of Sichuan University
Chengdu, Sichuan, 610000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.